captopril (Capoten) reduces the risk of heart attack, stroke, and death in patients with hypertension
August 1998
New evidence now suggests captopril (Capoten) reduces the riskof heart attack, stroke, and death in patients with hypertension.
This is important.
Up until now, only beta-blockers and diuretics have beenshown to reduce cardiovascular morbidity and mortality.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive